{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:13:24Z","timestamp":1781090004239,"version":"3.54.1"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,4,25]]},"DOI":"10.1253\/circj.cj-25-0054","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:05:13Z","timestamp":1743026713000},"page":"574-583","source":"Crossref","is-referenced-by-count":5,"title":["Patterns and Timings of Recurrence After Fluoropolymer-Coated Drug-Eluting Stent Use for Femoropopliteal Artery Diseases\u3000\u2015 Results of the PLANET Study \u2015"],"prefix":"10.1253","volume":"89","author":[{"given":"Naoki","family":"Yoshioka","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya Heart Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sendai Kousei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Yokohama City Eastern Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yanagiuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rakuwakai Otowa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tenyoukai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Medical Center"},{"name":"Division of Vascular Surgery, Department of Surgery, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuro","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the LEADers PAD Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). <i>J Vasc Surg<\/i> 2007; 45(Suppl S): S5\u2013S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. <i>Lancet<\/i> 2013; 382: 1329\u20131340.","DOI":"10.1016\/S0140-6736(13)61249-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, et al. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): A randomised, non-inferiority trial. <i>Lancet<\/i> 2018; 392: 1541\u20131551.","DOI":"10.1016\/S0140-6736(18)32262-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: Long-term results of the IN.PACT SFA randomized trial. <i>Circ Cardiovasc Interv<\/i> 2018; 11: e005891.","DOI":"10.1161\/CIRCINTERVENTIONS.118.006699"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ogata K, Nishihira K, Asano Y, Honda Y, Yamamoto K, Emori H, et al. Clinical comparison of drug-coated balloon and drug-eluting stent for femoropopliteal lesions in chronic limb-threatening ischemia with wounds. <i>Circ J<\/i> 2024; 88: 1647\u20131655.","DOI":"10.1253\/circj.CJ-24-0176"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. <i>Eur Heart J<\/i> 2024; 45: 3538\u20133700.","DOI":"10.1093\/eurheartj\/ehae179"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, et al. 1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: Predictors of restenosis and aneurysmal degeneration. <i>JACC Cardiovas Interv<\/i> 2022; 15: 630\u2013638.","DOI":"10.1016\/j.jcin.2022.01.019"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Fujihara M, et al. High-dose drug-coated balloon versus polymer-based drug-eluting stent for femoropopliteal artery disease treatment. <i>J Endovasc Ther<\/i> 2024, doi:10.1177\/15266028241267759.","DOI":"10.1177\/15266028241267759"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nordanstig J, Behrendt CA, Baumgartner I, Belch J, B\u00e4ck M, Fitridge R, et al. Editor\u2019s Choice -- European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication. <i>Eur J Vasc Endovascu Surg<\/i> 2024; 67: 9\u201396.","DOI":"10.1016\/j.ejvs.2023.08.067"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iida O, Uematsu M, Soga Y, Hirano K, Suzuki K, Yokoi H, et al. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. <i>Catheter Cardiovasc Interv<\/i> 2011; 78: 611\u2013617.","DOI":"10.1002\/ccd.23064"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, et al. Three-year clinical course after fluoropolymer-based drug-eluting stent implantation for femoropopliteal lesions. <i>Vasc Med<\/i> 2024; 29: 182\u2013188.","DOI":"10.1177\/1358863X241228261"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications. <i>Catheter Cardiovasc Interv<\/i> 2014; 83: E212\u2013E220.","DOI":"10.1002\/ccd.25387"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC). <i>J Am Coll Cardiol<\/i> 2015; 65: 931\u2013941.","DOI":"10.1016\/j.jacc.2014.12.036"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, et al. 1-Year results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of restenosis. <i>JACC Cardiovasc Interv<\/i> 2015; 8: 1105\u20131112.","DOI":"10.1016\/j.jcin.2015.03.022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, et al. Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. <i>J Endovasc Ther<\/i> 2017; 24: 367\u2013375.","DOI":"10.1177\/1526602817698634"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sakamoto A, Torii S, Jinnouchi H, Fuller D, Cornelissen A, Sato Y, et al. Vascular response of a polymer-free paclitaxel-coated stent (Zilver PTX) versus a polymer-coated paclitaxel-eluting stent (Eluvia) in healthy swine femoropopliteal arteries. <i>J Vasc Interv Radiol<\/i> 2021; 32: 792\u2013801.e5.","DOI":"10.1016\/j.jvir.2021.02.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Soga Y, Fujihara M, Tomoi Y, Iida O, Ishihara T, Kawasaki D, et al. One-year late lumen loss between A polymer-coated paclitaxel-eluting stent (Eluvia) and a polymer-free paclitaxel-coated stent (Zilver PTX) for femoropopliteal disease. <i>J Atheroscler Thromb<\/i> 2020; 27: 164\u2013171.","DOI":"10.5551\/jat.50369"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tsujimura T, Iida O, Ishihara T, Asai M, Masuda M, Okamoto S, et al. Angioscopic evaluation of vascular response after fluoropolymer-based drug-eluting stent implantation for femoropopliteal artery lesions. <i>Circ J<\/i> 2023; 87: 432\u2013429.","DOI":"10.1253\/circj.CJ-22-0635"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ishihara T, Inoue K, Iida O, Hata Y, Mano T. Pathological evaluation 18 years after bare-metal stent implantation in the superficial femoral artery. <i>J Cardiol Cases<\/i> 2021; 23: 94\u201397.","DOI":"10.1016\/j.jccase.2020.10.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yoshioka N, Tokuda T, Koyama A, Yamada T, Shimamura K, Nishikawa R, et al. Two-year clinical outcomes and predictors of restenosis following the use of polymer-coated paclitaxel-eluting stents or drug-coated balloons in patients with femoropopliteal artery disease. <i>Heart Vessels<\/i> 2023; 38: 429\u2013437.","DOI":"10.1007\/s00380-022-02182-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakao S, Iida O, Takahara M, Okamoto S, Ishihara T, Tsujimura T, et al. Impact of procedural techniques on midterm patency of fluoropolymer-based drug-eluting stent placed in the femoropopliteal artery. <i>J Vasc Interv Radiol<\/i> 2024; 35: 259\u2013268.","DOI":"10.1016\/j.jvir.2023.10.018"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ichihashi S, Takahara M, Yamaoka T, Hara M, Kobayashi T, Tamai H, et al. Drug eluting versus covered stent for femoropopliteal artery lesions: Results of the ULTIMATE study. <i>Eur J Vasc Endovascu Surg<\/i> 2022; 64: 359\u2013366.","DOI":"10.1016\/j.ejvs.2022.05.046"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. <i>J Vasc Surg<\/i> 2011; 54: 1058\u20131066.","DOI":"10.1016\/j.jvs.2011.03.286"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. <i>Circ Res<\/i> 2017; 120: 229\u2013243.","DOI":"10.1161\/CIRCRESAHA.116.308537"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Davignon J, Jacob RF, Mason RP. The antioxidant effects of statins. <i>Coron Artery Dis<\/i> 2004; 15: 251\u2013258.","DOI":"10.1097\/01.mca.0000131573.31966.34"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Taqueti VR, Ridker PM. Lipid-lowering and anti-inflammatory benefits of statin therapy: More than meets the plaque. <i>Circ Cardiovasc Imaging<\/i> 2017; 10: e006676.","DOI":"10.1161\/CIRCIMAGING.117.006676"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. <i>Nat Med<\/i> 2000; 6: 1399\u20131402.","DOI":"10.1038\/82219"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mart\u00ednez-Gonz\u00e1lez J, Badimon L. Influence of statin use on endothelial function: From bench to clinics. <i>Curr Pharm Des<\/i> 2007; 13: 1771\u20131786.","DOI":"10.2174\/138161207780831220"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Violi F, Calvieri C, Ferro D, Pignatelli P. Statins as antithrombotic drugs. <i>Circulation<\/i> 2013; 127: 251\u2013257.","DOI":"10.1161\/CIRCULATIONAHA.112.145334"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2024; 83: 2497\u20132604.","DOI":"10.1161\/CIR.0000000000001251"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Colantonio LD, Hubbard D, Monda KL, Mues KE, Huang L, Dai Y, et al. Atherosclerotic risk and statin use among patients with peripheral artery disease. <i>J Am Coll Cardiol<\/i> 2020; 76: 251\u2013264.","DOI":"10.1016\/j.jacc.2020.05.048"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/5\/89_CJ-25-0054\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T03:15:06Z","timestamp":1745637306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/5\/89_CJ-25-0054\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0054","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"article-number":"CJ-25-0054"}}